Tripeptides useful in immune and CNS therapy

Details Tripeptides useful in immune and CNS therapy Tripeptides useful in immune and CNS therapy

1993-08-26

1997-06-17

Chan, Christina Y.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530331, A61K 3800, A61K 3802, C07K 500, C07K 700

Patent

active

056397291

ABSTRACT:
Tripeptides capable of regulating the function of cells of the mammalian immune and/or central nervous system, pharmaceutical compositions containing the peptides and methods of use thereof are provided.

REFERENCES:
patent: 4190646 (1980-02-01), Goldstein et al.
patent: 4505853 (1985-03-01), Goldstein et al.
patent: 4629723 (1986-12-01), Goldstein et al.
patent: 5013723 (1991-05-01), Sisto et al.
patent: 5028592 (1991-07-01), Lipton
Websters II Dictionary p. 1230.
R. Merrifield, "Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide", J. Amer. Chem. Soc., 85:2149-2154 (Jul. 20, 1963).
T. Wieland, "Solution vs. Solid-Phase Methods in Peptide Chemistry", in Techniques in protein Chemistry, pp. 59-80, by Academic Press, Inc., New York (1978).
T. Audhya et al, "Isolation and Complete Amino Acid Sequence of Human Thymopoetin and Splenin", Proc. Natl. Acad. Sci. USA, 84:3545-3549 (1987).
G. Heavner et al, "Peptide Analogs of Thymopentin Distinguish Distinct Thymopoietin Receptor Specificities on Two Human T Cell Lines", Regulatory Peptides, 27:257-262 (1990) [Heavner I].
G. Chipens et al, "Localization and Steric Structure of Active Sites and Fragments of Ig Molecules", in LPSR Zinatnu Akademija, (198 ) [Chipens I].
G. Chipens et al, "Synthesis of Immunoproteins: New Biologically Active Low-Molecular Weight Fragments of Immunoglobulins", Bioorganicheskaya Kimiya, 11(4):437-446 (1985) [Chipens II].
G. Heavner et al, "Biologically Active Analogs of Thymopentin with Enhanced Enzymatic Stability", Peptides, 7:1015-1019 (1986) [Heavner II].
R. H. Brown et al, "Immunoreactive Thymopoietin in the Mouse Central Nervous System", Brain Research, 381:237-243 (1986).
K. Venkatasubramanian et al, "Binding of Thymopoietin to the Acetylcholine Receptor", Proc. Natl. Acad. Sci. USA, 83:3171-3174 (1986).
M. Quik et al, "Evidence for Thymopoietin and Thymopoietin/ .alpha.-Bungarotoxin/Nicotinic Receptors within the Brain", Proc. Natl. Acad. Sci. USA, 88:2603-2607 (1991) [Quik I].
M. Quik et al, "Thymopoietin and Thymic Polypeptide, Specifically Interacts at Neuronal Nicotinic .alpha.-Bungarotoxin Receptors", J. Neurochem., 53(4):1320-1323 (1989) [Quik II].
F. Revah et al, "Calcium-Dependent Effect of the Thymic Polypeptide Thymopoietin on the Desensitization of the Nicotinic Acetylcholine Receptor" Proc. Natl. Acad Sci USA, 84:3477-3481 (1987).
M. Quik et al, "Thymopoietin Inhibits Function and Ligand Binding to Nicotinic Receptors at the Neuromuscular Junction", J. Pharm. and Exp. Therap., 254(3):1113-1119 (1990) [Quik III].
M. Weksler et al, "Immunological Studies of Aging IV. The Contribution of Thymic Involution to the Immune Deficiencies of Aging Mice and Reversal with Thymopoietin", J. Exp. Med., 148: 996-1006 (1978).
E. Sundal et al, "Therapy with Thymopentin: A Clinical Overview", Immune Regulation by Characterized Polypeptides, pp. 121-136 (1987).
Merrifield, "Solid Phase Synthesis", Angew. Chem. Int. (ed. Engl.), 24:799-892.
Rajnavogyi et al, "The Influence of New Thymopoietin Derivatives in the Immune Response of Inbred Mice", Chem. Abst., 105:74, Abstract No. 105:800X (1986).
Kassai Tanczos et al, "Submolecular Acid-Base Properties of Bioligands. III. Microspeciation of Thymopoietin-type Tetrapeptides and their Derivatives", Chem. Abst., 115:1053, Abstract No. 136769h (1991).
B. Noszal et al, "Acid-Base Properties of Thymopoietin-type Tri- and Tetrapeptides and their Derivatives", Chem. Abst., 115\:992, Abstract No. 183935u (1991).
H. Kalbacher et al, "Acid Labile Protection of Histidine and Arginine in SPPS using Adpoc Derivatives", Chem. Abst., 115:1079, Abstract No. 208510s (1991).
V. Klusa et al, "Thymopentin Antagonizes Stress-Induced Changes of GABA/Benzodiazepine Receptor Complex", Regulatory Peptides, 27:355-365 (1990).
G. Chipens et al, "Localization and Steric Structure of Active Sites and Fragments of Ig Molecules", in LPSR Zinatnu Akademija (1984) [Chipens I].
A. Costa et al, "Effects of Etoperidone on Sympathetic and Pituitary-Adrenal Responses to Diverse Stressors in Humans", Clin. Neuropharm., 16(2):127-138 (1993).
E. Merlo-Pich et al, "Blockade of Pituitary-Adrenal Axis Activation Induced by Peripheral Immunoneutralization of Corticotropin-Releasing Factor does not Affect the Behavioral Response to Social Defeat Stress in Rats", Psychoneuroendocrinology, 18(7):495-507 (1993).
S Pellow et al, "Validation of Open:Closed Arm Entries in an Elevated Plus-Maze as a Measure of Anxiety in the Rat", J. Neurosci. Meth., 14:149-167 (1985) [Pellow I].
S. Pellow et al, "Anxiolytic and Anxiogenic Drug Effects on Exploratory Activity in an Elevated Plus-Maze: a Novel Test of Anxiety in the Rat", Pharmacol. Biochem. Behavior, 24:525-529 (1986) [Pellow II].
D. Ramsay, "Effects of Circulating Angiotensin II on the Brain", Frontiers in Neuroendocrinology, 7:263-285 (1982).

Affiliated with

Also associated with

Rating

Tripeptides useful in immune and CNS therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tripeptides useful in immune and CNS therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tripeptides useful in immune and CNS therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2157806